Potential therapeutic initiatives for fibrogenic lung diseases

Chest

Volumn 108, Issue 3, 1995, Pages 848-855

  Goldstein, R H ^a   Fine, A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antioxidants; growth factors; pulmonary fibrosis; type I collagen

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

DRUG RESEARCH; FIBROBLAST; FIBROGENESIS; HUMAN; LUNG FIBROSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029155678     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.108.3.848     Document Type: Article

References (97)

1. Weber KT Sun Y Tyagi SC Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26 1994 279 292
2. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 259 1990 L159 84
3. Riley DJ Kerr JS Berg RA Prevention of bleomycin-induced pulmonary fibrosis in the hamsters by cis-4-hydroxypro-line-1-proline. Am Rev Respir Dis 123 1981 388 393
4. du Bois RM. Idiopathic pulmonary fibrosis. Annu Rev Med 44 1993 441 450
5. Johnson MA Kwan S Snell NJ Randomised controlled trial compared prednisolone alone with cyclophosphamide with low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44 1989 280 288
6. Raghu G Depaso WJ Cain K Azathioprine combined with prednisone in the treatment of pulmonary fibrosis: a prospective double-blind randomized, placebo-controlled clinical trial. Am Rev Respir Dis 144 1991 291 296
7. Dayton CS Schwartz DA Helmers RA Outcome of subjects with idiopathic pulmonary fibrosis who fail corticsteroid therapy: implications for further studies. Chest 103 1993 69 73
8. Baughman RP Lower EE. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest 102 1992 1090 1094
9. Peters SG McDougall JC Douglas WW Colchicine in the treatment of pulmonary fibrosis. Chest 103 1993 101 104
10. Moolman JA Bardin PG Rossouw DJ Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax 46 1991 592 595
11. Jimenez SA Sigal SH. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine. J Rheumatol 18 1991 1496 1503
12. Rosenfeld MA Yoshimura K Trapnell BC In vivo transfer of the human cystic fibrosis transmembrane conductance regulatory gene to the airway epithelium. Cell 68 1992 143 155
13. Rich DP Couture LA Cardoza LM Development of recombinant adenoviruses of gene therapy of cystic fibrosis. Hum Gene Ther 4 1993 461 476
14. Standiford TJ Rolfe MW Kunkel SL Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J Immunol 151 1993 2852 2863
15. Ozaki T Hayaski H Tani K Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis Am Rev Respir Dis 145 1992 85 91
16. Stone PJ Lucey EC Snider GL Effect of diet on urinary excretion of desmosine and hydroxylysyl pyridinoline. Am J Respir Crit Care Med 149 1994 174 177
17. Kawamura M Yamasawa F Ishizaka A Serum concentration of 7S collagen and prognosis in patients with the adult respiratory distress syndrome. Thorax 49 1994 144 146
18. Low RB Giancola MS King TE Jr Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis 146 1992 701 706
19. Shijubo N Imai K Aoki S Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 89 1992 58 62
20. Satoh H Kamma H Ogata T Clinical significance of serum levels of a carbohydrate antigen, sialyl SSEA-1, in patients with fibrosing lung disease. Am Rev Respir Dis 144 1991 1177 1181
21. Korfhagen TR Swantz RJ Wert SE Respiratory epithelial cell expression of human transforming growth factor-α induces lung fibrosis in transgenic mice. J Clin Invest 93 1994 1691 1699
22. Piquet PF Vesin C Grau GE Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5 1993 57 61
23. Piguet PF Vesin C. Treatment by recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 7 1994 515 518
24. Piguet PF Grau GE de Kossodo S. Role of granulocyte-macrophage colony-stimulating factor in pulmonary fibrosis induced in mice by bleomycin. Exp Lung Res 19 1993 579 587
25. Zhang Y Lee TC Guillemin B Enhanced IL-1ß and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150 1993 4188 4196
26. Kline JN Schwartz DA Monick MM Relative release of interleukin-1ß and interleukin-1 receptor antagonist by alveolar macrophages: a study in asbestos-induced lung disease, sarcoidosis and idiopathic pulmonary fibrosis. Chest 104 1993 47 53
27. Piguet PF Ribaux C Karpuz V Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 143 1993 651 655
28. Nash JRG Mclaughlin PJ Butcher D Expression of tumour necrosis factor-α in crytogenic fibrosing alveolitis. Histopathology 22 1993 343 347
29. 2 release, alveolitis, and disease severity in sarcoidosis. Chest 103 1993 832 838
30. Piquet PF Collart MA Grau GE Requirement for tumor necrosis factor for development of silica induced pulmonary fibrosis. Nature 344 1990 245 247
31. Kang JH Lewis DM Castranova V Inhibitory action of tetrandrine on macrophage production of interleukin-1 (IL-1)-like activity in thymocyte proliferation. Exp Lung Res 18 1992 715 729
32. Broudy VC Kaushansky K Segal GM Tumor necrosis factor type-α stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 83 1987 7467 7471
33. 2. J Clin Invest 77 1986 1857 1863
34. Herrmann F Oster W Meuer SC Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor. J Clin Invest 81 1988 1415 1418
35. Janson RW King TE Hance KR Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am Rev Respir Dis 148 1993 495 503
36. Rubbia-Brandt L Sappino A-P Gabbiani G. Locally applied GM-CSF induces the accumulation of α-smooth muscle actin containing myofibroblasts. Virchows Arch B 60 1991 73 82
37. Vyalov SL Gabbiani G Kapanci Y. Rat alveolar myofibroblasts acquire α-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 143 1993 1754 1765
38. Krummel TM Michna BA Thomas BL Transforming growth factor-ß (TGF-ß) induced fibrosis in a fetal wound model. J Pediatr Surg 23 1988 647 652
39. Ignotz RA Massagué J. Transforming growth factor-ß stimulates the expression of fibronectin and collagen and their encorporation into the extracellular matrix. J Biol Chem 261 1986 4337 4345
40. Fine A Goldstein RH. The effect of transforming growth factor-ß on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 262 1987 3897 3902
41. Kähäri V-M Olsen DR Rhudy RW Transforming growth factor-ß up-regulates elastin gene expression in human skin fibroblasts: evidence for post-transcriptional modulation. Lab Invest 66 1992 580 588
42. Massague J. The transforming growth factor family. Annu Rev Cell Biol 6 1990 597 641
43. Keski-Oja J Raghow R Sawdey M Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type 1 procollagen by transforming growth factor-ß: divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem 263 1988 3111 3115
44. Ritzenthaler J Goldstein RH Fine A Transforming growth factor ß activation elements in the distil promoter regions of the rat α1 type I collagen gene. Biochem J 280 1991 157 162
45. Inagaki Y Truter S Ramirez F. Transforming growth factor-ß stimulation of α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 269 1994 14828 14834
46. MacLellan WR Lee TC Schwartz RJ Transforming growth factor-ß response elements of the skeletal α-actin gene: combinatorial action of serum response element, YY1 and the SV 40 enhancer binding protein, TEF-1. J Biol Chem 269 1994 16754 16760
47. Roberts AB Sporn MB. The transforming growth factor-betas. Sporn M Roberts AB Peptide growth factors and their receptors. 1990 Springer-Verlag Heidelberg, Germany 421 472
48. Massagué J. Receptors for the TGF-ß family. Cell 69 1992 1067 1070
49. Miyazono K ten Dijke P Ichijo H Receptors for transforming growth factor-ß. Adv Immunol 55 1994 181 220
50. Andres JL Stanley K Cheifetz S Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-ß. J Cell Biol 109 1989 3137 3145
51. Ruoslahi E Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 64 1991 867 869
52. Yamaguchi Y Mann DM Ruoslahti E. Negative regulation of transforming growth factor-ß by the proteoglycan decorin. Nature 346 1990 281 284
53. Border WA Noble NA Yamamoto T Natural inhibitor of transforming growth factor-ß protects against scarring in experimental kidney disease. Nature 360 1992 361 364
54. Broekelmann TJ Limper AH Colby TV Transforming growth factor ß 1 is present at site of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88 1991 6642 6646
55. Khalil N Bereznay O Sporn M Macrophage production of transforming growth factor ß and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 170 1989 727 737
56. Phan SH Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Cell Res 18 1992 29 43
57. Giri SN Hyde DM Hollinger MA. Effect of antibody to transforming growth factor-ß on bleomycin induced accumulation of lung collagen in mice. Thorax 48 1993 959 966
58. Moreland LW Goldsmith KT Russell WJ Transforming growth factor-ß within fibrotic scleroderma lungs. Am J Med 93 1992 628 636
59. Shull MM Ormsby I Kier AB Targeted disruption of the mouse transforming growth factor-ß 1 gene results in multifocal inflammatory disease. Nature 359 1992 693 699
60. Takeuchi Y Yoshiaki K Matsumoto T. Bone matrix decorin binds transforming growth factor-ß and enhances its bioactivity. J Biol Chem 269 1994 32634 32638
61. Rinaldo J Goldstein RH Snider GL. Modification of oxygen toxicity following lung injury by bleomycin in hamsters. Am Rev Respir Dis 126 1982 1030 1033
62. Haschek WM Witschi H. Pulmonary fibrosis: a possible mechanism. Toxicol Appl Pharmacol 51 1979 475 487
63. Nakashima JM Levin JR Hyde DM Repeated exposure to enzyme-generated oxidants causes alveolitis, epithelial hyperplasia, and fibrosis in hamsters. Am J Pathol 139 1991 1485 1499
64. Borzi RM Grigolo B Meliconi R Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis. Clin Sci 85 1993 353 359
65. Parizada B Werber MM Nimrod A. Protective effect of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 15 1991 297 301
66. Sato S Nakamura H Takada K Dietary vitamin E supplement does not inhibit changes in lung pressure-volume characteristics produced by bleomycin in hamsters. Eur Respir J 1 1988 523 526
67. Schaberg T Rau M Stephan H Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Am Rev Respir Dis 147 1993 1507 1513
68. Piquet PF Rosen H Vesin C Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Respir Dis 147 1993 435 441
69. Borok Z Buhl R Grimes GJ Effect of glutathione aerosal in oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338 1991 215 216
70. Cantin AM Hubbard RC Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139 1989 370 372
71. Gordon RE Heller RF Heller RF. Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment. Adv Exp Med Biol 315 1992 319 328
72. Giri SN Wang Q. Taurine and niacin offer a novel therapeutic modality in prevention of chemically induced pulmonary fibrosis in hamsters. Adv Exp Med Biol 315 1992 329 340
73. Dolara P Agresti A Giotti A Effect of taurine on calcium exchange of sarcoplasmic reticulum of guinea pig heart studied by means of dialysis kinetics. Can J Physiol Pharmacol 54 1975 529 533
74. 2+-accumulation in rat brain synaptosomes. J Neurochem 34 1980 244 246
75. Wang QJ Giri SN Hyde DM Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol 42 1991 1115 1122
76. Schraufstatter IU Hyslop PA Hinshaw DB Hydrogen peroxide-induced lung injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 83 1986 4908 4912
77. Dallegri F Goretti R Ballestrero A Neutrophil-induced depletion of adenosine triphosphate in target cells: evidence for a hypochlorous acid-mediated process. J Lab Clin Med 112 1988 765 772
78. O'Neill CA Giri SN. Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP. Exp Lung Res 20 1994 41 56
79. Meyer A Buhl R Magnussen H. The effect of oral N-acetylcyteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur Respir J 7 1994 431 436
80. Shahzeidi S Sarnstrand B Jeffery PK Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J 4 1991 845 852
81. Akohori F Nagata T Masaoka T Effect of dehydroxyproline as a collagen synthetic inhibitor in paraquat-induced pulmonary fibrosis in beagle dogs. Vet Hum Toxicol 35 1993 216 222
82. Geismar LS Kerr JS Trelstad RL Treatment of experimental silicosis with antifibrotic agents. Toxicology 53 1988 331 344
83. 2 on transforming growth factor-ß and insulin-induced collagen formation in lung fibroblasts. J Biol Chem 264 1989 16988 16991
84. 2 causes a coordinate decrease in steady state levels of fibronectin and types I and III procollagens in normal dermal fibroblasts. Biochem Biophy Res Commun 147 1987 1282 1288
85. Borok Z Gillissen A Buhl R Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosal administration of prostaglandin E. Am Rev Respir Dis 144 1991 1080 1084
86. Mall G Zimmermann P Siemens I Prevention of bleomycin-induced fibrosing alveolitis with indomethacin: stereological studies on rat lungs. Virchows Arch A 419 1991 339 347
87. Prior C Haslam PL. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung disease. Clin Exp Immunol 88 1992 280 287
88. Okada T Sugie I Aisaka K. Effects of γ-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats. Lymphokine Cytokine Res 12 1993 87 91
89. Zia S Hyde DM Giri SN. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters. Pharmacol Toxicol 71 1992 11 18
90. Hyde DM Giri SN. Polyinosinic-polycytidylic acid, an interferon inducer, ameliorates bleomycin-induced lung fibrosis in mice. Exp Lung Res 16 1990 533 546
91. Tan LB Jalil JE Pick R Cardiac myocyte necrosis induced by angiotensin II. Circ Res 69 1991 1185 1195
92. Jahil JE Janicki JS Pick R Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: response to captopril. Am J Hypertens 4 1991 51 55
93. Kuzuo H Honda M Ishinaga Y Angiotension converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing collagen types and concentration in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 20 1993 253 260
94. Mukherjee D Sen S. Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure. J Mol Cell Cardiol 25 1993 185 196
95. Brilla CG Matsubara LS Weber KT. Anti-andosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 25 1993 563 575
96. Ward WF Molteni A Ts'ao C-H Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 19 1990 1405 1409
97. Nguyen L Ward WF Ts'ao C-H Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism. Proc Soc Exp Biol Med 205 1994 80 84